Financials
Reported figures only · latest: Q4 2025
USD · IFRS
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | $376.1M | $2.9M |
|---|
| FY24 | $297.2M | −$11.8M |
|---|
| FY23 | $245.3M | −$10.5M |
|---|
| FY22 | $205.6M | $13.7M |
|---|
| FY21 | $198.9M | $16M |
|---|
| FY20 | $212.2M | $37.7M |
|---|
| FY19 | $189.4M | $40.6M |
|---|
| FY18 | - | - |
|---|
MarginsShare of revenue- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|
| FY25 | 87.9% | 6.9% | 0.8% |
|---|
| FY24 | 88.1% | −2.9% | −4% |
|---|
| FY23 | 89.7% | −2.2% | −4.3% |
|---|
| FY22 | 91.5% | 8.9% | 6.7% |
|---|
| FY21 | 89.4% | 6.8% | 8% |
|---|
| FY20 | 88.9% | 35.9% | 17.8% |
|---|
| FY19 | 87.4% | 36% | 21.4% |
|---|
| FY18 | - | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | $54M |
|---|
| FY24 | −$2.6M |
|---|
| FY23 | −$18.7M |
|---|
| FY22 | $21.1M |
|---|
| FY21 | $27.1M |
|---|
| FY20 | $79M |
|---|
| FY19 | $71.5M |
|---|
| FY18 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- Pharming
- Healthcare median
Show the numbers
| Year | Pharming | Healthcare median |
|---|
| FY25 | 0.8% | −30.6% |
|---|
| FY24 | −4% | −47% |
|---|
| FY23 | −4.3% | −58% |
|---|
| FY22 | 6.7% | −80.4% |
|---|
| FY21 | 8% | −71.9% |
|---|
| FY20 | 17.8% | −62.2% |
|---|
| FY19 | 21.4% | −46.3% |
|---|
| FY18 | - | −49.6% |
|---|